Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kronos Bio, Inc.

0.7545
-0.0160-2.08%
Post-market: 0.75450.00000.00%18:29 EDT
Volume:106.41K
Turnover:81.16K
Market Cap:46.00M
PE:-0.53
High:0.7882
Open:0.7800
Low:0.7420
Close:0.7705
Loading ...

Piper downgrades Kronos Bio on istisociclib discontinuation

TIPRANKS
·
14 Nov 2024

Kronos Bio downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
14 Nov 2024

Kronos Bio Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $1 From $6

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Inc : TD Cowen Cuts to Hold From Buy

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

TD Cowen downgrades Kronos Bio (KRON) to a Hold

TIPRANKS
·
14 Nov 2024

Kronos Bio downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
14 Nov 2024

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
14 Nov 2024

Kronos Bio Q3 2024 GAAP EPS $(0.23) Beats $(0.26) Estimate, Sales $2.37M Beat $2.10M Estimate

Benzinga
·
14 Nov 2024

BRIEF-Kronos Bio Q3 EPS USD -0.23

Reuters
·
14 Nov 2024

Kronos Bio Inc - to Evaluate Strategic Alternatives

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Q3 Cash & Investments USD 124.9 Million

THOMSON REUTERS
·
14 Nov 2024

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

GlobeNewswire
·
14 Nov 2024

Kronos Bio's Market Cap Drops To US$50m Leaving Insiders With Losses

Simply Wall St.
·
10 Nov 2024

Kronos Bio Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
08 Nov 2024

BRIEF-Kronos Bio Inc Says Receives Non-Compliance Notice From Nasdaq - SEC Filing

Reuters
·
08 Nov 2024

BRIEF-Kronos Bio Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Reuters
·
08 Nov 2024

Kronos Bio Inc Says Receives Non-Compliance Notice From Nasdaq - SEC Filing

THOMSON REUTERS
·
08 Nov 2024

Kronos Bio Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing

THOMSON REUTERS
·
08 Nov 2024

Kronos Bio to present data at ASH annual meeting on p300 KAT inhibitor program

TIPRANKS
·
05 Nov 2024